Stock Research: Mediclinic

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Mediclinic

LSE:MDC GB00B8HX8Z88
n/a
  • Value
    n/a
  • Growth
    n/a
  • Safety
    Safety
    n/a
  • Combined
    n/a
  • Sentiment
    n/a
  • 360° View
    360° View
    n/a
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description
Analysis
n/a
more
Index
FTSE All Shares
FTSE 250
FTSE 350
Employee Focus EU
Diversity Europe
Good Governace Growth Markets
Low Waste
JSE All Shares
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: .

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
n/a n/a 73 87
Growth
n/a n/a 49 43
Safety
Safety
n/a n/a 55 48
Sentiment
n/a n/a 38 12
360° View
360° View
n/a n/a 52 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
n/a n/a 45 52
Opinions Change
n/a n/a 50 50
Pro Holdings
n/a n/a 70 30
Market Pulse
n/a n/a 9 11
Sentiment
n/a n/a 38 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
n/a n/a 73 87
Growth
n/a n/a 49 43
Safety Safety
n/a n/a 55 48
Combined
n/a n/a 71 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
n/a n/a 67 78
Price vs. Earnings (P/E)
n/a n/a 79 97
Price vs. Book (P/B)
n/a n/a 82 91
Dividend Yield
n/a n/a 51 63
Value
n/a n/a 73 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
n/a n/a 65 16
Profit Growth
n/a n/a 74 77
Capital Growth
n/a n/a 33 17
Stock Returns
n/a n/a 33 63
Growth
n/a n/a 49 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
n/a n/a 26 18
Refinancing
n/a n/a 73 87
Liquidity
n/a n/a 39 36
Safety Safety
n/a n/a 55 48

Similar Stocks

Discover high‑ranked alternatives to Mediclinic and broaden your portfolio horizons.

Exxaro

JSE:EXX
Country: South Africa
Industry: Coal & Consumable Fuels
Size: Medium
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Tiger Brands

JSE:TBS
Country: South Africa
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Harmony

JSE:HAR
Country: South Africa
Industry: Gold Production
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.